Losing weight fast takes some of your muscle with it. Here is how to slow that down
There's a scene that plays out a lot: someone starts dropping weight fast, their clothes hang loose within three months and everyone tells them how good they look. And yet they feel weaker going up stairs, they struggle with things they used to lift easily, and they can't figure out why. The scale says one thing and the body says another.
The scale goes down, and not all of it is fat
When you lose weight, you lose it from several places at once. Fat goes, yes, but so does water, and so does lean mass, which is the label for everything in you that isn't fat: muscle, bone, organs. The trouble is that a bathroom scale can't tell them apart, so it hands you a number and you decide what story to tell yourself about it.
This happens with any kind of weight loss, including an old-fashioned diet. But it has become a talking point because of GLP-1 drugs, the weekly injections better known by brand names like Ozempic or Wegovy. They bring weight down fast, and the faster it comes down, the louder the question gets about what exactly is leaving. And if speed changes that split, it helps to know what pace is worth aiming for: Losing fat without rushing: why going slow is the fast way to keep it off.
What shows up when you pool 22 trials and 2,258 people
A meta-analysis that carries real weight on this question appeared in Metabolism in 2025. Researchers pooled 22 randomized trials with 2,258 participants in total, adults with diabetes or with overweight and obesity. They measured weight, fat and lean mass separately instead of looking only at the total.
Here are the average numbers. Total weight dropped by 3.55 kilos. Fat dropped by 2.95 kilos. Lean mass dropped by 0.86 kilos, so run the division and roughly a quarter of all the weight lost was not fat. That figure is why any conversation about these drugs ends up turning to muscle.
The detail almost nobody mentions, and it calms things down
Here comes the part that usually gets left out of the headlines, and it deserves to be in. The same authors also measured lean mass in relative terms, meaning what share of the body it made up before and after. That share did not shift in any meaningful way.
Put plainly, kilos of lean mass were lost, but kilos of fat were lost too, and the balance between them stayed broadly the same. This isn't the picture of a body being emptied of muscle; it's the picture of a body getting smaller fairly proportionally. There's still reason to act, but not reason to panic.
The whole story matters. A lot of what gets written on this is meant to frighten you, and a lot of it is meant to sell you something. The data supports a duller and more useful conclusion: you lose some muscle, and there's a known way to make that loss smaller.
These drugs do not all behave the same way
The same work found differences between them, and those differences matter: the most powerful ones for weight loss, tirzepatide and semaglutide at their higher doses, were also the ones that held on to lean mass worst. The faster the weight comes off, the harder it is for muscle to keep up.
At the other end sat liraglutide, the only one in the group that produced meaningful weight loss without a meaningful drop in lean mass. That's an interesting finding for whoever runs the clinic rather than for whoever reads a blog, because which drug, at what dose and for how long is a decision your doctor makes with your history in front of them, not one you settle by reading an article.
Bone is part of this equation too
Lean mass includes bone, and there is something worth looking at there too. In February 2026, a team at Weill Cornell Medicine published an analysis in the Journal of Clinical Endocrinology and Metabolism. They compared people treated with semaglutide or tirzepatide for at least six months, nine in ten of them women and 64 years old on average, against similar people who were not taking them, matched for age, sex, body mass index and whether they had diabetes.
Among those without diabetes who were using the drugs to lose weight, hip bone density fell more than in the comparison group over 17 months. The gap was small in absolute terms, though. Hip density fell by 1% in the treated group against 0.6% in the comparison group.
What that study can't tell you about fractures
Lower density sounds like more fragile bone, and the obvious question is whether that turns into more broken bones. That study can't answer it, because it measured density rather than fractures. What it did find is that hip density fell in both groups, and that among people with diabetes the loss was about the same whether or not they took these drugs. Among those on the drugs, the more weight they lost, the more bone went with it.
So the honest picture is this: there's a measurable signal in bone density, while the thing that actually counts, ending up in the emergency room with something broken, wasn't measured here. Those are different things, and it's worth keeping them apart. What we do know is that bone responds to load, and that part is already in our hands.
What actually protects muscle while the weight comes off
Here the science is old, solid and pretty boring, which is exactly what you want in a recommendation. In 2025, a review in Frontiers in Nutrition pooled 62 randomized trials with 4,429 healthy participants, covering the literature up to 2024. The question it set out to answer was which kind of exercise works best when someone is eating less than they burn.
The answer was that pairing the deficit with exercise, and specifically with strength work, is what best preserves lean mass while fat keeps dropping. Nor did it take the hardest version: strength work at low or moderate intensity ranked among the best options.
It makes sense when you think it through, because your body keeps the muscle it has a reason to keep. If you eat less and ask nothing of it, it reads that tissue as an expense it can drop. If you eat less but every two or three days you ask it to move a load, the math comes out differently.
How much protein your body wants when you eat less
The other pillar is what goes on the plate. In January 2025, Refalo and colleagues published a review of 29 studies in non-obese people with at least three months of lifting behind them, aimed at exactly this question: how much protein it takes to hold on to fat-free mass while in a deficit and lifting. The reference figure they work with, based on the body of earlier data, sits at around 1.6 grams per kilo of body weight per day.
For someone who weighs 70 kilos, that's about 112 grams spread across the day rather than dumped into dinner. If you want to see that in real food and without awkward arithmetic, we walk through it in how much protein you actually need. And there's a wrinkle specific to these drugs. They blunt appetite, so hitting your protein target gets harder exactly when it matters most.
What this article is not saying, said plainly
It isn't saying these medicines are bad: they're medical tools that have changed life for a lot of people with obesity and with diabetes, and that part isn't up for debate here. It isn't saying you should start taking them or stop taking them either. That conversation belongs with your doctor, who knows your history, your bloodwork and your situation.
What it is saying is something smaller and a good deal more useful. If you're going to lose weight, by whatever route, some of what leaves will be muscle, and you have a known lever to keep that share as small as possible. The lever is lifting and eating enough protein. It works the same whether your weight loss comes from a drug or from a change in your kitchen.
It's also worth naming what these data don't settle. Body composition studies work with group averages, and your own case can sit well away from the average. This work measured body composition and bone density, not function, meaning whether those people ended up lifting less or climbing stairs worse, so that question sits outside what it looked at.
Two or three sessions, and where they fit in your week
You can start this week, and you don't need a complicated plan. Two or three sessions of 30 to 60 minutes each, choosing exercises that spread the work across half your body rather than isolating small muscles. Legs pressing against a resistance, arms pulling something toward you, arms pressing something away, and the back working with the hips. Use a weight that makes the last few reps hard, and take it up slowly.
And there's a reason not to leave it for later. If you're in the middle of losing weight, every week that goes by without training is a week where it gets decided, without any input from you, how much of what you lose is fat and how much is not. Muscle you keep now is muscle you don't have to rebuild later. Rebuilding is the expensive part.
If you've never touched a barbell, at Gym Triple X that's where it starts, learning the movement with light weight and someone correcting you until it runs on its own. You don't need to arrive knowing anything, or fit, or with a plan in hand. You'll look at the scale either way, and what happens to your muscle while that number falls is the part you get to decide.
And if while reading this you have thought that your case asks for a closer hand, someone who looks at your situation instead of giving general advice, that role exists and it is called a personal trainer on the Costa del Sol. It is not always necessary. It is worth asking yourself honestly before starting another attempt on your own.
Sources
- Metabolism (2025). Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis.
- The Journal of Clinical Endocrinology & Metabolism (2026). Skeletal effect of semaglutide and tirzepatide in patients with increased risk of fractures.
- Frontiers in Nutrition (2025). Comparing exercise modalities during caloric restriction: a systematic review and network meta-analysis on body composition.
- Strength & Conditioning Journal (2025). Effect of Dietary Protein on Fat-Free Mass in Energy Restricted, Resistance-Trained Individuals: An Updated Systematic Review With Meta-Regression.